Membranous glomerulonephritis pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Membranous glomerulonephritis}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Needs content Category:Disease [[Category:Kidney d...")
 
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
==Pathophysiology==
MGN is caused by circulating [[immune complex]]. Current research indicates that the majority of the immune complexes are formed via binding of antibodies to antigens ''in situ'' to the glomerular basement membrane. The said antigens may be [[endogenous]] to (from) the basement membrane, or "planted" from systemic circulation.
The immune complex serves as an activator that triggers a response from the C5b - C9 complements, which form a [[Complement_membrane_attack_complex|membrane attack complex]] (MAC) on the glomerular epithelial cells. This, in turn, stimulates release of proteases and oxidants by the mesangial and epithelial cells, damaging the capillary walls and causing them to become "leaky". In addition, the epithelial cells also seem to secrete an unknown mediator that reduces nephrin synthesis and distribution.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 20:08, 27 September 2012

Membranous glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Membranous glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Membranous glomerulonephritis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Membranous glomerulonephritis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Membranous glomerulonephritis pathophysiology

CDC on Membranous glomerulonephritis pathophysiology

Membranous glomerulonephritis pathophysiology in the news

Blogs on Membranous glomerulonephritis pathophysiology

Directions to Hospitals Treating Membranous glomerulonephritis

Risk calculators and risk factors for Membranous glomerulonephritis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

MGN is caused by circulating immune complex. Current research indicates that the majority of the immune complexes are formed via binding of antibodies to antigens in situ to the glomerular basement membrane. The said antigens may be endogenous to (from) the basement membrane, or "planted" from systemic circulation.

The immune complex serves as an activator that triggers a response from the C5b - C9 complements, which form a membrane attack complex (MAC) on the glomerular epithelial cells. This, in turn, stimulates release of proteases and oxidants by the mesangial and epithelial cells, damaging the capillary walls and causing them to become "leaky". In addition, the epithelial cells also seem to secrete an unknown mediator that reduces nephrin synthesis and distribution.

References

Template:WH Template:WS